Survival Benefits and Less Intensive Treatment for Women with Early-Stage Breast Cancer Diagnosed While Participating in Population-Based Screening.

ABSTRACT:

Background

The authors previously reported that within a patient cohort from Victoria, Australia, women who had early-stage breast cancer (ESBC) diagnosed while participating in screening [active screeners (AS), comprising both screen-detected and interval cancers] receive less intensive treatment than those not recently screened (NRS). This study reports mortality and subsequent cancer events for that cohort.

Methods

Follow-up data were collected for 766 (97.1%) of the 789 women in the original cohort (612 [79.9%] AS and 154 [20.1%] NRS), with a median follow-up time of 11.6 years (interquartile range [IQR], 9.8-13.8 years). Mortality and subsequent cancer diagnosis data were derived from linkage with the Victorian Cancer Registry. Breast cancer-specific survival (BCSS) and

SUBMITTER: Edwards M 

PROVIDER: S-EPMC12494613 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature